ArticleFrontiers in oncology2025
Application and improvement of YOLO11 for brain tumor detection in medical images.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Review
- Brain tumor detection on magnetic resonance imaging scans using the artificial intelligence-based You Only Look Once algorithm.The Journal of international medical research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Brain tumors pose a critical threat to human health, and early detection is essential for improving patient outcomes. This study presents two key enhancements to the YOLOv11 architecture aimed at improving brain tumor detection from MRI images. First, we integrated a set of novel attention modules (Shuffle3D and Dual-channel attention) into the network to enhance its feature extraction capability. Second, we modified the loss function by combining the Complete Intersection over Union (CIoU) with a Hook function (HKCIoU). Experiments conducted on a public Kaggle dataset demonstrated that our improved model reduced parameters and computations by 2.7% and 7.8%, respectively, while achieving mAP50 and mAP50-95 improvements of 1.0% and 1.4%, respectively, over the baseline. Comparative analysis with existing models validated the robustness and accuracy of our approach.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.